Funded Research

The MRF has funded millions of dollars in melanoma research since 1998.

The Melanoma Research Foundation is proud to award research grants supporting the study of melanoma prevention, diagnosis and treatment across the spectrum of the disease, including cutaneous, ocular and mucosal melanoma. These include the following:

  • Team Awards (established in 2014) - Two-year awards, up to 0,000 per year
  • Established (Senior) Investigator Awards (established in 2006) - Two-year awards, up to 0,000 per year
  • Career Development (Junior) Awards (established in 1998) - Two-year awards, up to ,000 per year
  • Medical Student Awards (established in 2011) - One-year awards, up to ,000
  • Society for Melanoma Research Young Investigator Awards (sponsored by the MRF since 2013) - One-year awards, ,000 per year
  • Society for Melanoma Research Christopher J. Marshall Award (sponsored by the MRF since 2015) - One-year awards, ,000 per year

View a summary of the 2019 Research Recipients here.

Non-viral engineering of T cells with enhanced tumorcidal potential activity for melanoma immunotargeting

Medical Student Award 2014
Principal Investigator: Rebecca Jonas
Institution: Thomas Jefferson University


Age and sex differences in localized cutaneous melanoma survival and progression: A Mayo Clinic Population-Based Retrospective Cohort Study on Melanoma

Medical Student Award 2014
Principal Investigator: Jeannette Olazagasti Lourido
Institution: The Mayo Clinic


Methylated DNA shed in serum from metastatic melanoma as a biomarker following surgery

Medical Student Award 2014
Principal Investigator: Nathaniel Slater
Institution: University of North Carolina at Chapel Hill


Interdiction of signaling by G-alpha-q to treat ocular melanoma

Established Investigator – CURE OM 2012
Principal Investigator: John Sondek, PhD
Institution: University of North Carolina at Chapel Hill
Established Investigator Award – CURE OM


Dissecting therapeutic avenues in UM through genomic and functional studies

Established Investigator – CURE OM 2012
Principal Investigator: Dr. Levi Garraway
Institution: Dana-Farber Cancer Institute
CURE OM funded


Role of human antimicrobial peptide cathelicidin and mast cells in IL-9 mediated melanoma immunity

Medical Student Award 2013
Principal Investigator: Keith Roby
Institution: University of California, San Diego School of Medicine


A potential role for Rec8 in genomic instability during melanomagenesis

Medical Student Award 2013
Principal Investigator: Scott Lindsey
Institution: University of Miami Miller School of Medicine


Investigating a Role for the Oculocutaneous Albinism Type 2 (OCA2) Protein and p53 pathway in melanoma chemoresistance

Medical Student Award 2013
Principal Investigator: Andrew Kim
Institution: NYU School of Medicine


Defining the role of CD2 in disease progression and overall survival among patients with resectable primary melanoma

Medical Student Award 2013
Principal Investigator: Sara Harcharik
Institution: Mount Sinai School of Medicine


Antidepressants and melanoma: Is there a link?

Medical Student Award 2013
Principal Investigator: Stephanie Douglas
Institution: Yale University School of Medicine